Immunovant, Inc. IMVT Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Immunovant, Inc.’s 10-Q, filed February 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s common stock, shares, outstanding?
- Immunovant, Inc. (IMVT) reported common stock, shares, outstanding of $203.32M in Q4 2025.
- How has Immunovant, Inc.'s common stock, shares, outstanding changed year-over-year?
- Immunovant, Inc.'s common stock, shares, outstanding increased by 38.1% year-over-year, from $147.2M to $203.32M.
- What is the long-term trend for Immunovant, Inc.'s common stock, shares, outstanding?
- Over 4 years (2021 to 2025), Immunovant, Inc.'s common stock, shares, outstanding has grown at a 14.8% compound annual growth rate (CAGR), from $97.97M to $170.11M.